Please check your internet connection and try again.
# Arsil-DX (Dextromethorphan/Chlorpheniramine)
## Overview
Arsil-DX is a combination product typically containing dextromethorphan (an antitussive) and chlorpheniramine (a first-generation antihistamine). It is indicated for the symptomatic relief of cough and upper respiratory symptoms associated with common colds or allergies.
## Primary Indications
* Cough suppression.
* Relief of rhinorrhea and sneezing associated with the common cold or allergic rhinitis.
## Adult Dosing
* **Standard dose:** 10 mL (or specific product concentration equivalent) every 4 to 6 hours as needed.
* **Maximum daily dose:** Do not exceed 4 doses in 24 hours. Always check the specific product label, as concentrations vary by manufacturer.
## Pediatric Dosing
* **Children 6 to 12 years:** 5 mL every 4 to 6 hours, not to exceed 4 doses in 24 hours.
* **Children <6 years:** Generally **not recommended** due to a narrow therapeutic index and lack of safety data. Consult a pediatrician; many guidelines advise against OTC cough/cold preparations in children under age 4–6.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific adjustment guidelines exist; however, caution is advised as chlorpheniramine may accumulate, increasing anticholinergic effects in elderly patients or those with hepatic dysfunction. Use with caution in patients with severe impairment.
## Contraindications
* Hypersensitivity to dextromethorphan, chlorpheniramine, or any component of the formulation.
* Concurrent use of Monoamine Oxidase Inhibitors (MAOIs) or use within 14 days of MAOI discontinuation (risk of serotonin syndrome).
* Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction.
## Adverse Effects
* **CNS:** Drowsiness (common), dizziness, sedation, confusion.
* **Anticholinergic:** Dry mouth, blurred vision, urinary retention, constipation.
* **Cardiac:** Palpitations or tachycardia.
## Key Drug Interactions
* **MAOIs:** Risk of severe hyperpyrexia, hypertensive crisis, and death.
* **CNS Depressants:** Alcohol, opioids, or benzodiazepines may significantly potentiate sedation.
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome due to the serotonergic activity of dextromethorphan.
## Monitoring
* Monitor for excessive sedation or respiratory depression.
* Assess for relief of cough or reduction in respiratory symptoms.
* In elderly patients, monitor closely for anticholinergic side effects (e.g., urinary retention, delirium).
## Clinical Pearls
* **Sedation:** Advise patients to avoid driving or operating heavy machinery until the effects of the medication are known.
* **Combination Products:** Warn patients against taking multiple "cold/flu" medications simultaneously to prevent unintentional overdose (e.g., duplicate ingestion of acetaminophen or other antihistamines).
* **Duration:** If the cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache, advise the patient to seek medical evaluation.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug concentrations for "Arsil-DX" may vary by manufacturer, regional availability, or generic labeling. Always verify the current, specific concentration and dosing guidelines via the product label (Drug Facts) or a clinical drug database before prescribing or administering.
